Nat Calloway

Nat Calloway is a seasoned healthcare analyst with extensive experience in the pharmaceutical and biotechnology sectors. Currently holding the position of Healthcare Analyst at English Capital Partners since June 2021, Nat also serves as a Board Member for Lifecore Biomedical and Anebulo Pharmaceuticals. Previous experience includes a role as Associate Director at Edison Group, providing valuable insights in healthcare analysis, along with earlier positions in equity research and as a senior research analyst. Nat's academic credentials include a PhD in Chemistry and Chemical Biology from Cornell University, as well as a Master's degree from Columbia University and a Bachelor's degree from the University of North Carolina at Chapel Hill.